minimal cytochrome enzyme inhibition for most compounds. Although squalene and stigmasterol exhibited
high efficacy, they also showed predicted neurotoxicity and cardiotoxicity. In contrast, β-caryophyllene and
vanillin derivatives offered a favorable balance of efficacy and safety, making them promising candidates for
further investigation. Toxicity screening revealed that while some compounds were moderately toxic, most
were non-mutagenic and non-cytotoxic. However, prediction of neurotoxicity, cardiotoxicity, and
immunotoxicity for squalene and stigmasterol (with probabilities > 0.85) at high dosage raises caution for dose
selection and necessitates further in vivo toxicological evaluation.
REFERENCES
1. Akinjogunla, O. J., Adegoke, A. A., Udokang, I. P., & Adebayo-Tayo, B. C. (2014). Antibacterial
and phytochemical evaluation of Tetrapleura tetraptera Taub. pod extracts.
2. Adedokun, M. O., & Onakoya, O. A. (2021). Antimicrobial and antiviral potentials of Piper
guineense (Uziza): A review. Journal of Medicinal Plants Research, 15(6), 245–253.
3. Asanga, E. A., Johnson, J. T., Iwuanyanwu, T. P., & Ibe, C. J. (2024a). Computational Prediction
of pharmacokinetic and ADMET properties of bioactive compounds. Journal of Computational
Chemistry, 45(3), 233–245.
4. Bayan, L., Koulivand, P. H., & Gorji, A. (2014). Garlic: A review of potential therapeutic effects.
Avicenna Journal of Phytomedicine, 4(1), 1–14.
5. Boivin, G., Abed, Y., Pelletier, G., Ruel, L., Moisan, D., Côté, S., Peret, T. C. T., Erdman, D. D.,
Anderson, L. J., & Boucher, F. D. (2002). Virological features and clinical manifestations
associated with human metapneumovirus: A new paramyxovirus responsible for acute respiratory-tract
infections in all age groups. Journal of Infectious Diseases, 186(9), 1330–1334.
6. Daina, A., Michielin, O., &Zoete, V. (2019).SwissADME: a free web tool to evaluate
pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules. Scientific
Reports, 7, 42717.
7. Falsey, A. R., Erdman, D., Anderson, L. J., & Walsh, E. E. (2003). Human Metapneumovirus
infections in young and elderly adults. New England Journal of Medicine, 349, 2289–2295.
8. Hoogen, V. D., de-Jong, B.G, Groen, J. C., Kuiken, J., de Groot, H.Y., Fouchier, R. & Osterhaus, A.
D. M. E. (2001). A newly discovered human pneumovirus isolated from young children with
respiratory tract disease. Nature Medicine, 7(6), 719–724.
9. Hoogen, V.D., van-Doornum, B. G., Fockens, G. J., Cornelissen, J. C., Beyer, J. J., Osterhaus, J. C. &
Fouchier, R. A. M. (2003). Prevalence and clinical symptoms of human metapneumovirus infection in
hospitalized patients. The Journal of Infectious Diseases, 188(10), 1571–1577.
10. Kamboj, M., Gerbin, M., Huang, C. K., Brennan, C., Stiles, J., Balashov, S., & Sepkowitz, K. A.
(2008). Clinical characteristics of human metapneumovirus infection among patients with cancer.
Clinical Infectious Diseases, 46(12).
11. Kouassi, K. C., N’Guessan, J. D., Kouadio, Y. J., Kra, A. M., & Zirihi, G. N.
(2020).Antimicrobial and antiviral activities of Xylopia aethiopica. Journal of Applied Biosciences,
149, 15368–15379.
12. Lionta, E., Spyrou, G., Vassilatis, D. K., & Cournia, Z. (2014). Structure-based virtual screening
for drug discovery: Principles, applications and recent advances. Current Topics in Medicinal
Chemistry, 14(16), 1923–1938.
13. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and
computational approaches to estimate solubility and permeability in drug discovery and development
settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26.
14. Oladimeji, O. H., &Usifoh, C. O. (2015).Phytochemical and antimicrobial studies on some Nigerian
medicinal plants.Journal of Pharmacy & Bioresources, 12(2), 156–164.
15. Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., &Kopple, K. D. (2002).
Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal
Chemistry, 45(12), 2615–2623.
16. Lipinski, C. A. (2021). Drug-like properties and the causes of poor solubility and poor
permeability.Journal of Pharmacokinetics and Pharmacodynamics, 48(1), 15–28.